Approved by the Board in December 2012 and extended until 30 June 2015, the Task Force has already achieved significant traditional law enforcement outcomes, including: � seizing more than $37.86 million cash � seizing drugs and precursors with a combined estimated street value of more than $642 million through seizures in all states � dismantling the largest ever clan lab discovered in Victoria � discovering the largest indoor hydroponic cannabis crop in New South Wales � seizing one of the largest amounts of liquid methylamphetamine in Victoria (365 litres in April 2013 in Melbourne) � restraining more than $30 million worth of assets and the referral of over 150 entities to the Australian Taxation Office (ATO) for suspected money laundering/tax evasion � disrupting 25 serious and organised criminal groups/networks � identifying more than 180 targets previously unknown to law enforcement � arresting 167 people on 362 charges, including many serious drug

Notes the February 2016 passage of the federal Narcotic Drugs Amendment Bill 2016 enabling a national licensing scheme for the controlled cultivation across Australia of cannabis for medicinal and scientific purposes; II.

Notes the February 2016 passage of the federal Narcotic Drugs Amendment Bill 2016 enabling a national licensing scheme for the controlled cultivation across Australia of cannabis for medicinal and scientific purposes; II.

Notes the February 2016 passage of the federal Narcotic Drugs Amendment Bill 2016 enabling a national licensing scheme for the controlled cultivation across Australia of cannabis for medicinal and scientific purposes; II.

While the implications of this observation are discussed in detail in Chapter 4 of this report, Figure 3.1 below illustrates the average value of these contracts; several industries (such as the human pharmaceutical and medicinal product manufacturing industry) are excluded as the small number of contracts procured from these industries skew the representation of the data for the majority of the industries.

Assoc. with Physi- Mental Retarda- tion No Psychia- tric Diagnosis Totals Total Per Cent of Total Per Cent Change from cal Cond. 1973 -74 Addiction M F 4 2 4 2 446 111 13.08 325 +0.68 +33.73 No Addiction M F 39 30 181 140 33 34 28 8 184 146 18 14 1 360 1 493 39.88 43.78 +3.42 +1-70 Total M F 43 32 185 142 33 34 28 8 184 146 18 14 1 806 1 604 52.96 47.04 +2.73 +3.42 Total 75 327 67 36 330 32 3 410 +3.05 26 TABLE 17 IN-PATIENTS-TOTAL ADMISSIONS, 1974 -75 Diagnosis by Addiction to Drugs Diagnosis Senile and Pre - senile Dementia Alcoholic Psychosis Other Organic Psychoses Schizo- phrenia and Para- noid States Depressive Psychosis Other Functional Psychoses Depressive Neurosis Other Neuroses and Psychoso- matic Disorders Alcoholism Type of Drug Opium M - - - - - - - Synthetic Analgesics M - - - - - - - Barbiturates MF-- -- _- -- -- -- - - - Other Hypnotics M - - - - - - - - Cocaine MF-- -- -- -- - -- -- -- - Cannabis Sativa MF-- -- -- -

Detection Statistics for CGTF commencing November 2007: o 499 arrests / reports of OMCG members o 1088 arrests/reports of associates and those linked to OMCGs o The seizure of 330 firearms o 728 premises searched of OMCG members (including clubrooms) o 871 premises searched of associates and those linked to OMCGs o Seizure of $2.33 million in cash o Seizure of 1280 cannabis plants o Seizure of 61,000 street deals of loose cannabis o Seizure of 72,000 street deals of methamphetamine o Seizure of 34,500 street deals of ecstasy o Seizure of 10,980 street deals of other drugs o 394 barring orders issued o 39 current OMCG have current firearm prohibition orders.

These, and also medicinal plants, can be grown in such places without trouble.

Combined with our expertise in the quality use of medicines, pharmaceutical science and pharmacokinetcs research, our recent appointments of international research leaders in cancer medicinal therapy and innovative drug formulation, the Centre was an unmissable opportunity to contribute to the worldwide battle against cancer.

XIX Chemicals, medicinal and pharmaceutical products, etc.